Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) declared a quarterly dividend on Friday, August 7th. Stockholders of record on Friday, August 21st will be paid a dividend of 0.20 per share on Friday, September 4th. This represents a c) dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date of this dividend is Friday, August 21st.
Bath & Body Works has increased its dividend by an average of 0.2%per year over the last three years. Bath & Body Works has a payout ratio of 20.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Bath & Body Works to earn $2.90 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 27.6%.
Bath & Body Works Price Performance
Shares of Bath & Body Works stock traded up $0.20 during trading on Friday, hitting $20.34. The company’s stock had a trading volume of 4,635,723 shares, compared to its average volume of 5,629,001. Bath & Body Works has a 52 week low of $14.27 and a 52 week high of $32.32. The stock has a market cap of $4.10 billion, a price-to-earnings ratio of 5.71, a price-to-earnings-growth ratio of 2.06 and a beta of 1.38. The stock has a 50-day moving average price of $20.30 and a two-hundred day moving average price of $20.29.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. Telsey Advisory Group reduced their price target on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research report on Thursday, May 28th. Piper Sandler started coverage on Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 price objective for the company. TD Cowen lifted their price objective on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Weiss Ratings upgraded Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. Finally, UBS Group decreased their target price on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Bath & Body Works presently has an average rating of “Hold” and an average price target of $21.93.
Check Out Our Latest Research Report on Bath & Body Works
About Bath & Body Works
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
